This study showed the presence of four recurrently mutated genes, represented by APC, TP53, KRAS, and PIK3CA. Furthermore, according to the somatic tumor burden, metastatic CRCs can be distinguished into three groups: normal, hypermutated, ultramutated. This evidence concerns the gene TP53 and neoplasm.